Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens

被引：0
|
作者：
Yeh, H. [1 ]
Katz, A. [1 ]
机构：
[1] AstraZeneca, Ft Washington, MD USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
744
引用
收藏
页码：S357 / S357
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of sitagliptin compared with dapagliflozin in patients with type 2 diabetes, mild renal impairment, and inadequate glycaemic control on metformin ± a sulfonylurea
    Raji, A.
    Scott, R.
    Morgan, J.
    Zimmer, Z.
    Lam, R. L. H.
    O'Neill, E. A.
    Kaufman, K. D.
    Engel, S. S.
    [J]. DIABETOLOGIA, 2018, 61 : S379 - S380
  • [32] Efficacy and safety of supaglutide as add-on to metformin in patients with type 2 diabetes
    Anwar, D.
    Bao, Y.
    Zhou, Y.
    Chen, S.
    Zhou, J.
    Li, L.
    Cheng, Z.
    Dong, X.
    Shi, X.
    Zhao, N.
    Yang, Y.
    Ma, J.
    Li, Y.
    Wang, Q.
    Jia, W.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S322
  • [33] Efficacy and Safety of Supaglutide as Add-on to Metformin in Patients with Type 2 Diabetes
    Anwar, Dilbar
    Bao, Yuqian
    Zhou, Yue
    Chen, Si
    Zhou, Jian
    Li, Liang
    Cheng, Zhifeng
    Dong, Xiaolin
    Shi, Xiaoxia
    Su, Xiuhai
    Li, Liping
    Wang, Haifang
    Wang, Yihua
    Li, Shu
    Li, Qingju
    Li, Xing
    Liu, Ming
    Sun, Jiao
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Wang, Qinghua
    Jia, Weiping
    [J]. DIABETES, 2023, 72
  • [34] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [35] Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients
    Ito, Hiroyuki
    Ohno, Yasuhiro
    Yamauchi, Takaaki
    Kawabata, Yumiko
    Ikegami, Hiroshi
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2011, 11 (01) : 55 - 62
  • [36] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, J
    Magner, J
    Krol, A
    Taylor, T
    [J]. DIABETES, 1998, 47 : A351 - A351
  • [37] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Magner, J
    Taylor, T
    Krol, A
    Rosenstock, J
    [J]. DIABETOLOGIA, 1998, 41 : A231 - A231
  • [38] Efficacy and safety of alogliptin added to metformin therapy in patients with type 2 diabetes
    Nauck, Michael
    Ellis, Graham
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    [J]. DIABETES, 2008, 57 : A142 - A143
  • [39] Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes
    Rosenstock, J
    Brown, A
    Fischer, J
    Jain, A
    Littlejohn, T
    Nadeau, D
    Sussman, A
    Taylor, T
    Krol, A
    Magner, J
    [J]. DIABETES CARE, 1998, 21 (12) : 2050 - 2055
  • [40] Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial
    Araki, Eiichi
    Onishi, Yukiko
    Asano, Michiko
    Kim, Hyosung
    Yajima, Toshitaka
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (04): : 562 - 570
12345